Anti-ATG7 Antibody, clone 1E15 ZooMAb^® Rabbit Monoclonal

rabbit

200

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

1E15, monoclonal
recombinant monoclonal

ZooMAb^® learn more

lyophilized

calculated mol wt ~ 77.96 kDa
observed mol wt ~ 65 kDa

rat, human, mouse

antibody small pack of 25 μL

recombinant expression
Learn more about Antibody Enhanced Validation

affinity binding assay: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
western blot: suitable

IgG

ambient

2-8℃

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.

Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.

Clone 1E15 is a ZooMAb^® rabbit recombinant monoclonal antibody that specifically detects Autophagy related protein 7 (ATG7). It targets an epitope within 13 amino acids from the N-terminal region. It is expected to react with all tree isoforms of ATG7.

KLH-conjugated linear peptide corresponding to 13 amino acids from the N-terminal region of human Autophagy-related protein 7 (ATG 7).

Quality Control Testing

Evaluated by Western Blotting in HeLa cell lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected ATG7 in HeLa cell lysate.

Tested Applications

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected ATG7 in NIH3T3 and C6 cell lysates

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected ATG7 in human placenta tissue sections.

Affinity Binding Assay: A representative lot of this antibody bound ATG7 peptide with a KD of 2.4 x 10-7 in an affinity binding assay.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-ATG7, clone 1E15 ZooMAb^®, Cat. No. ZRB1235, is a recombinant Rabbit monoclonal antibody that specifically targets ATG7 and has been tested for use in Affinity Binding Assay, Immunohistochemistry (Paraffin), and Western Blotting.

Purified recombinant mouse monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Ubiquitin-like modifier-activating enzyme ATG7 (UniProt: O95352; also known as ATG12-activating enzyme E1 ATG7, Autophagy-related protein 7, APG7-like, hAGP7, Ubiquitin-activating enzyme E1-like protein) is encoded by the ATG7 (also known as APG7L) gene (Gene ID: 10533) in human. ATG7 is the E1-like activating enzyme that is involved in the 2 ubiquitin-like systems required for cytoplasm to vacuole transport and autophagy. It is widely expressed, especially in kidney, liver, lymph nodes and bone marrow. Its expression is reported to be upregulated by the transcription factor HSF1. ATG7 interacts with ATG3 and ATG12 and the ATG3-ATG7 complex plays a role in the conjugation of ATG12 to ATG5. The C-terminal region of ATG7 is shown to be essential for the dimerization and interaction with ATG3 and ATG12. Its N-terminal region contains a FAP motif (aa 15-17), which is essential for the formation of ATG7-ATG3 interaction. ATG7 is essential for hematopoietic stem cell maintenance and its absence from the hematopoietic lineage abolishes development of T and B cells. Three isoforms of ATG7 have been described that are produced by alternative splicing. This ZooMAb^® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Tanida, I., et al. (2012). Autophagy. 8(1); 88-97; Mortensen, M., et al. (2011). J. Exp. Med. 208(3); 455-467).

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

11 - Combustible Solids

WGK 1